These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25933001)

  • 21. Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria.
    Tang WK; Salinas ND; Kolli SK; Xu S; Urusova DV; Kumar H; Jimah JR; Subramani PA; Ogbondah MM; Barnes SJ; Adams JH; Tolia NH
    Nat Commun; 2024 Aug; 15(1):7487. PubMed ID: 39209843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
    Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
    Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.
    Sun P; Schwenk R; White K; Stoute JA; Cohen J; Ballou WR; Voss G; Kester KE; Heppner DG; Krzych U
    J Immunol; 2003 Dec; 171(12):6961-7. PubMed ID: 14662904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.
    Cabrera-Mora M; Fonseca JA; Singh B; Oliveira-Ferreira J; Lima-Junior Jda C; Calvo-Calle JM; Moreno A
    Infect Immun; 2015 Sep; 83(9):3749-61. PubMed ID: 26169267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
    Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The
    López C; Yepes-Pérez Y; Díaz-Arévalo D; Patarroyo ME; Patarroyo MA
    Front Cell Infect Microbiol; 2018; 8():156. PubMed ID: 29868512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
    de Camargo TM; de Freitas EO; Gimenez AM; Lima LC; de Almeida Caramico K; Françoso KS; Bruna-Romero O; Andolina C; Nosten F; Rénia L; Ertl HCJ; Nussenzweig RS; Nussenzweig V; Rodrigues MM; Reyes-Sandoval A; Soares IS
    Sci Rep; 2018 Jan; 8(1):1118. PubMed ID: 29348479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.
    Brahimi K; Badell E; Sauzet JP; BenMohamed L; Daubersies P; Guérin-Marchand C; Snounou G; Druilhe P
    Infect Immun; 2001 Jun; 69(6):3845-52. PubMed ID: 11349050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
    Przysiecki C; Lucas B; Mitchell R; Carapau D; Wen Z; Xu H; Wang XM; Nahas D; Wu C; Hepler R; Ottinger E; Ter Meulen J; Kaslow D; Shiver J; Nardin E
    Front Cell Infect Microbiol; 2012; 2():146. PubMed ID: 23226683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K
    J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors.
    Atcheson E; Bauza K; Salman AM; Alves E; Blight J; Viveros-Sandoval ME; Janse CJ; Khan SM; Hill AVS; Reyes-Sandoval A
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria.
    Arévalo-Herrera M; Valencia AZ; Vergara J; Bonelo A; Fleischhauer K; González JM; Restrepo JC; López JA; Valmori D; Corradin G; Herrera S
    Parasite Immunol; 2002 Mar; 24(3):161-9. PubMed ID: 12078650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live attenuated pre-erythrocytic malaria vaccines.
    Keitany GJ; Vignali M; Wang R
    Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
    Mehrizi AA; Torabi F; Zakeri S; Djadid ND
    Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.
    Parra-López CA; Bernal-Estévez D; Yin L; Vargas LE; Pulido-Calixto C; Salazar LM; Calvo-Calle JM; Stern LJ
    PLoS One; 2014; 9(7):e100639. PubMed ID: 24983460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
    Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
    Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
    Chatterjee S; Wery M; Sharma P; Chauhan VS
    Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.